Global Biguanide Market Size, Share, Analysis, Industry Report and Forecast to 2026


Posted August 4, 2020 by Larebomrglobal123

Global Biguanide Market Size, Share & Trends Analysis Report, By Type, By Dosage Form and Forecast, 2020-2026
 
The global biguanide market is expected to show a considerable CAGR of more than 7.0% rate during the forecast period 2020-2026. Biguanide is a group of oral drugs used to treat type 2 diabetes. It works by reducing the amount of sugar released by the liver in the blood. In addition, it also improves the response of the body towards insulin. Metformin is the most common biguanide available in the global market. It is used as a first-line treatment for type 2 diabetes.

A full Report of Global Biguanide Market at https://www.omrglobal.com/industry-reports/biguanide-market

Increasing prevalence of type 2 diabetes cases all across the globe is the major factor for the increase in demand for the biguanide during the forecast period. As per the International Diabetes Federation (IDF), the global prevalence of diabetes in the age group of 20-79 years was 463 million in 2019. It is further estimated to reach 578 million by 2030. Moreover, annual global demand for Metformin drug is growing significantly owing to the increasing stature of the drug as a safe, proven, cost-effective, gold-standard drug of choice for treatment of diabetes. Moreover, the increasing demand for Metformin in combination with other drugs has encouraged major players in the global market. However, the presence of new alternatives for managing type 2 diabetes, and recall of the metformin are some of the major factors challenging market growth.

Request a Free Sample of Report on Global Biguanide Market @ https://www.omrglobal.com/request-sample/biguanide-market

Global Biguanide Market Segmentation

By Type

• Metformin IR (Immediate-Release)
• Metformin ER (Extended Release)
• Other Biguanide (Buformin, Phenformin, Chlorproguanil, Chloroguanide)

By Dosage Form

• Tablet
• Solution

Regional Analysis

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• Aarti Drugs Ltd.
• Amneal Pharmaceuticals, Inc.
• Apotex Corp.
• AstraZeneca PLC
• BOEHRINGER Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Cadila Healthcare Ltd.
• Dr. Reddy's Laboratories, Inc.
• Eli Lilly and Co.
• Glenmark Pharmaceuticals, Ltd.
• Harman Finochem Ltd.
• Lupin, Ltd.
• Marksans Pharma Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Shandong Keyuan Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd
• USV Pvt. Ltd.
• Vistin Pharma ASA

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/biguanide-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com
Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Lareb Khan
Phone 07803040404
Business Address 305, Commerce House, 308, 11 Bungalow Colony, New Palasia, Indore, Madhya Pradesh
Country India
Categories Health , Medical , News
Tags global biguanide market , healthcare , pharmaceuticals
Last Updated August 4, 2020